Back to search

Article

ALK1-BMPRII agonism by clustering bispecific antibodies treats hereditary hemorrhagic telangiectasia

2025-08-14

Abstract excerpt

Hereditary hemorrhagic telangiectasia (HHT) is characterized by arteriovenous malformations (AVMs) and severe bleeding caused by loss-of-function mutations in the ALK1 receptor pathway. We developed clustering agonist bispecific antibodies (BsAbs) targeting ALK1 and its activating partner, the Ser/Thr receptor kinase BMPRII. These BsAbs induced ALK1-BMPRII proximity association, stimulated the downstream Smad1/5/8...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
863b9b72-2c5c-5534-ac90-1d67b5706cf8
DOI
10.1101/2025.08.13.670104
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ALK1-BMPRII agonism by clustering bispecific antibodies treats hereditary hemorrhagic telangiectasiaDOI 10.1101/2025.08.13.670104
Select a neighboring publication to make it the new centre.